Contact

Click here for a confidential contact or call:

1-347-417-2192

Pharma Fraud

This archive displays posts tagged as relevant to pharmaceutical fraud. You may also be interested in our pages:

Page 23 of 39

Pfizer Agrees to Pay $23.85 Million to Resolve False Claims Act Liability for Paying Kickbacks

Posted  05/24/18
The Department of Justice today announced that Pfizer agreed to pay $23.85 million to resolve allegations that it used a foundation as a conduit to pay the copays of Medicare patients taking three Pfizer drugs. Medicare Part B or D beneficiaries typically make a partial payment when obtaining prescription drugs in the form of a copay, coinsurance, or deductible. Under the Anti-Kickback Statute, pharmaceutical...

Tagged in: Anti-Kickback and Stark, FCA Federal, Healthcare Fraud, Pharma Fraud,

Read More

Ex-Manager and CEO Convicted in $9.7 Million Valeant Kickback Scheme

Posted  05/23/18
By the C|C Whistleblower Lawyer Team Yesterday, a federal jury in Manhattan convicted Gary Tanner, a midlevel executive at Valeant Pharmaceuticals International, and Andrew Davenport, the CEO of Philidor Rx Services, of conspiring to bring about Valeant’s purchase of Philidor in exchange for a $9.7 million kickback. The scheme allegedly netted Davenport $40 million, and he kicked back a portion of it to...

Tagged in: Financial and Investment Fraud, Pharma Fraud,

Read More

April 26, 2018

Nicholas A. Borgesano Jr., owner of Florida pharmacy A to Z Pharmacy was sentenced to 180 months in prison and ordered to pay $54 million in restitution for his role in a massive compounding pharmacy fraud scheme. DOJ

Tagged in: Compounding Pharmacy Fraud, Pharma Fraud,

Jazz Pharmaceuticals Sets Aside $57M to Settle DOJ Probe

Posted  05/9/18
Jazz Pharmaceuticals Plc disclosed yesterday it has reached a tentative agreement to pay $57 million to resolve a Justice Department probe over its donations to charities that reduce drug prices for Medicare patients. The company manufactures Xyrem, a costly drug used to treat narcolepsy. Jazz had previously received multiple DOJ subpoenas concerning its charitable donations and announced the agreement in principle...

Tagged in: Pharma Fraud,

Read More

March 8, 2018

Kmart Corporation agreed to pay $525,000 to settle claims it violated the False Claims Act by submitting claims for reimbursement to California’s Medi‑Cal program that were not supported by applicable diagnosis and documentation requirements. The allegations originated in a whistleblower lawsuit filed under the qui tam provisions of the False Claims Act by a Kmart pharmacist. The whistleblower will receive a whistleblower award of roughly $96,500 from the proceeds of the government’s recovery. DOJ (EDCA)

Tagged in: FCA Federal, Medicaid, Medical Billing Fraud, Pharma Fraud, Whistleblower Case, Whistleblower Rewards,

Supreme Court Considers Revisiting Key FCA Decision

Posted  04/17/18
Supreme CourtBy the C|C Whistleblower Lawyer Team Yesterday, the justices asked the Trump Administration’s Office of the Solicitor General’s views on a petition for certiorari in United States ex rel. Campie v. Gilead Scis., a False Claims Act (FCA) suit against pharmaceutical giant Gilead Sciences. The suit, which was brought by two former Gilead employees turned whistleblowers, alleges the company made false statements...

Tagged in: FCA Federal, FCA Materiality, FDA Fraud, Pharma Fraud,

Read More

Martin Shkreli Sentenced to Seven Years in Prison for Fraud

Posted  03/12/18
By the C|C Whistleblower Lawyer Team The New York Times reported on Friday that Martin Shkreli, the former pharmaceutical executive nicknamed “Pharma Bro” was sentenced to seven years in prison related to his involvement in pharmaceutical company Retrophin and two hedge funds he operated. Shkreli is best known for raising the price of Daraprim, a drug to treat toxoplasmosis, by 5000% in 2015. In August, Shkreli...

Tagged in: Pharma Fraud,

Read More

United States Targets a Private-Equity Firm and Pharmacy in a Whistleblower Case

Posted  02/26/18
By the C|C Whistleblower Lawyer Team On Friday the Wall Street Journal reported on the U.S. government’s decision to intervene in a False Claims Act qui tam case against pharmacy Diabetic Care Rx LLC and the private equity firm that holds a controlling stake in the pharmacy, Riordan Lewis & Haden Equity Partners (“RLHEP”). Diabetic Care is a compounding pharmacy that mixes different ingredients to create...

Tagged in: Compounding Pharmacy Fraud, Defendants, FCA Federal, Other Government Health Programs, Pharma Fraud, Whistleblower Case,

Read More

Greek Parliament Opens Investigation into Pharmaceutical Bribery

Posted  02/22/18
By the C|C Whistleblower Lawyer Team After twenty hours of debate, the Greek Parliament has approved the creation of a committee to investigate accusations that Novartis, a Swiss pharmaceutical company, bribed at least ten high-level politicians. The investigation will now hold separate and secret votes on whether each of the ten involved politicians should be investigated. The list of politicians includes two...

Tagged in: FCPA, International Whistleblowers, Pharma Fraud,

Read More
1 … 21 22 23 24 25 … 39

Newsletter

Subscribe to receive email updates from the Constantine Cannon blogs

Sign up for: